| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/22/2009 | WO2009063223A1 Use of anti-bacterial compounds having an anaesthetic effect |
| 05/22/2009 | WO2009063221A2 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 05/22/2009 | WO2009062964A1 Novel solvate |
| 05/22/2009 | WO2009062963A1 Crystalline forms of tigecycline hydrochloride |
| 05/22/2009 | WO2009062737A1 Silibinin component for the treatment of hepatitis |
| 05/22/2009 | WO2009062348A1 Methods for inhibiting influenza virus infection and their drugs |
| 05/22/2009 | WO2009062308A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062289A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062288A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062258A1 N-containing heterocyclic compounds |
| 05/22/2009 | WO2009043507A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009043468A3 Use of corticotropin-releasing factor as a therapeutic agent |
| 05/22/2009 | WO2009040755A3 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 05/22/2009 | WO2009040552A3 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| 05/22/2009 | WO2009040087A3 Therapeutic use of peptide yglf and combination with kvlpvpq |
| 05/22/2009 | WO2009040073A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040032A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040025A3 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent |
| 05/22/2009 | WO2009039969A3 Use of a vla-4 inhibitor tetrapeptide, alone or in combination with bpp-b, as a therapeutic agent |
| 05/22/2009 | WO2009033822A3 Use of a combination of a cathepsin g fragment and teprotide as a therapeutic agent |
| 05/22/2009 | WO2009033812A3 Use of a combination of neuropeptide-ff and alpha-msh as a therapeutic agent |
| 05/22/2009 | WO2009033800A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009033771A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009033736A3 Use of met-enkephalin as a therapeutic agent |
| 05/22/2009 | WO2009033735A3 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 05/22/2009 | WO2009033669A3 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent |
| 05/22/2009 | WO2009025820A3 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| 05/22/2009 | WO2008136815A3 5, 6-ring annulated indole derivatives and use thereof |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705642A1 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 05/22/2009 | CA2705587A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705555A1 Compositions and methods for the therapy and diagnosis of influenza |
| 05/22/2009 | CA2705338A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705312A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2704536A1 Crystalline forms of tigecycline hydrochloride |
| 05/22/2009 | CA2703834A1 Silibinin component for the treatment of hepatitis |
| 05/22/2009 | CA2703600A1 N-containing heterocyclic compounds |
| 05/21/2009 | US20090131707 Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
| 05/21/2009 | US20090131655 Cephem Compounds Having Broad Antibacterial Spectrum |
| 05/21/2009 | US20090131652 Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof |
| 05/21/2009 | US20090131494 Non-Nucleoside Reverse Transcriptase Inhibitors |
| 05/21/2009 | US20090131481 Transcription Factor Modulating Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090131460 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131429 Pharmaceutical compounds |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131421 Compounds for proteasome enzyme inhibition |
| 05/21/2009 | US20090131414 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c |
| 05/21/2009 | US20090131401 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2009 | US20090131392 Phtalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
| 05/21/2009 | US20090131389 Preparation of a Crystalline Antibiotic Substance |
| 05/21/2009 | US20090131370 Novel Nucleoside Derivatives |
| 05/21/2009 | US20090131366 Use of Amine-Borane Compounds as Anti-Microbial Agents |
| 05/21/2009 | US20090131363 Deuterated darunavir |
| 05/21/2009 | US20090131352 Aptamers comprising arabinose modified nucleotides |
| 05/21/2009 | US20090131342 Nitrosated and/or nitrosylated compounds, compositions and methods of use |
| 05/21/2009 | US20090130762 Activation of HCV-specific T cells |
| 05/21/2009 | US20090130236 using a Sasa plant extract for treating herpes virus, influenza virus, corona virus infections |
| 05/21/2009 | US20090130233 Two part lotion |
| 05/21/2009 | US20090130181 Antibacterial Surface Treatments Based on Silver Cluster Deposition |
| 05/21/2009 | US20090130147 Capsular polysaccharide solubilisation and combination vaccines |
| 05/21/2009 | US20090130145 Vaccine |
| 05/21/2009 | US20090130143 Genetically modified porcine reproductive respiratory syndrome (PRRS) virus modified in the NLS-2 region, NoLS region, and/or the NES region of the nucleocapsid (N) protein such that the resultant PRRS virus is attenuated; reversion-resistant mutations; vaccines; DNA sequence encodes the infectious RNA |
| 05/21/2009 | US20090130141 Compositions and methods for stimulating an immune response against infectious agents |
| 05/21/2009 | US20090130140 Capsular Polysaccharide Solubilisation and Combination Vaccines |
| 05/21/2009 | US20090130138 Antiviral and antibacterial activity from medicinal mushrooms |
| 05/21/2009 | US20090130137 formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children; provides coverage for serotypes 6A and 19A |
| 05/21/2009 | US20090130128 Antiinfective Proanthocyanidin Compounds and Methods of Use Thereof |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130115 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 05/21/2009 | US20090130082 Compositions and methods for the treatment and prevention of infections caused by staphylococcus aureus bacteria |
| 05/21/2009 | US20090130074 Preparation of antigen-presenting human gamma delta t cells and use in immunotherapy |
| 05/21/2009 | US20090130058 Biologically active composition comprising ethylcellulose |
| 05/21/2009 | US20090130056 Compounds for the Treatment of Hepatitis C |
| 05/20/2009 | EP2060257A1 Prevention and treatment of secondary infections following viral infection |
| 05/20/2009 | EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 05/20/2009 | EP2060183A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 05/20/2009 | EP2059305A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 05/20/2009 | EP2059304A1 Treating mycobacterial infections with cyclipostins |
| 05/20/2009 | EP2059259A1 Pharmaceutical compositions for the treatment of fungal infections |
| 05/20/2009 | EP2059239A2 Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 05/20/2009 | EP2059237A2 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 05/20/2009 | EP1607091B1 Antihepatitis c virus agent and anti-hiv agent |
| 05/20/2009 | EP1401492B1 Ltb4 as vaccine adjuvant |
| 05/20/2009 | EP1392691B1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a] [1,4] benzodiazepines |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | EP1310502B1 Phosphonocephem compound |
| 05/20/2009 | EP1223975B1 MUCOSAL DTPa VACCINES |
| 05/20/2009 | EP0651789B2 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | DE102007055007A1 Verfahren zur Übertragung und Konservierung von Aroma- und Inhaltsstoffen von Pflanzen und/oder Pflanzenteilen auf eine ölhaltige Basissubstanz, angereicherte Basissubstanz und deren Verwendungen Method for transmitting and preserving and flavoring ingredients of plant and / or plant parts to a base substance containing oil-enriched base substance and uses thereof |
| 05/20/2009 | DE102007054985A1 Topical product, useful e.g. to prevent/treat relapses by herpes simplex I, comprises histone deacetylase activator comprising resveratrol, quercetin and/or luteolin, and additionally vitamin B12, vitamin B6, folic acid and betaine |
| 05/20/2009 | DE102007054877A1 Use of hyaluronidase e.g. as a drug for the treatment of profibrotic metabolic disorder, fibrotic liver disease, chronic viral liver disease, portal hypertension, chronic hepatitis C and hepatocellular carcinoma |
| 05/20/2009 | CN101437942A Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides |
| 05/20/2009 | CN101437826A Pentacyclic indole derivatives as antiviral agents |
| 05/20/2009 | CN101437824A Inhibitors of secretion of hepatitis B virus antigens for treatment of a chronic hepatitis virus |
| 05/20/2009 | CN101437529A Flavonoid compound having an antiviral activity |